منابع مشابه
Does Proton Therapy Have a Future in CNS Tumors?
OPINION STATEMENT Proton therapy is characterized by certain physical properties leading to a reduction in integral dose. As proton therapy becomes more widely available, the ongoing discussion on the real indications for proton therapy becomes more important. In the present article, data on proton therapy for tumors of the central nervous system (CNS) is summarized and discussed in view of mod...
متن کاملThe Use of Anthracyclines for Therapy of CNS Tumors
Despite being long lived, anthracyclines remain the "evergreen" drugs in clinical practice of oncology, showing a potent effect in inhibiting cell growth in many types of tumors, including brain neoplasms. Unfortunately, they suffer from a poor penetration into the brain when intravenously administered due to multidrug resistance mechanism, which hampers their delivery across the blood brain ba...
متن کاملProton Therapy of eye using MCNPX code
Introduction: Proton radiotherapy is the one of advanced teletherapy methods. The protons deposit their maximum energy in a position called Bragg peak. Therefore, for treatment of cancer, the tumor should be placed at the Bragg peak or SOBP. The scattered photons and neutrons is a challenge in proton radiotherapy. The aim of this study is calculation of absorbed dose from scatt...
متن کاملCRUSH PREPARATION CYTOLOGIC FINDINGS OF CNS TUMORS: A STUDY OF 199 CASES
Crush preparation cytology technique was used during the operative procedure for the diagnosis of 199 CNS tumors. This technique is simple, easy to perform, rapid, and inexpensive. The cytomorphologic findings were excellent and helped achieve a rapid and correct diagnosis. This technique was used on the tiny, small specimens which were not suitable for frozen sectioning. The results were c...
متن کاملPredicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers.
Using brain proton magnetic resonance spectroscopic imaging (MRSI) in children with central nervous system (CNS) tumors, we tested the hypothesis that combining information from biologically important metabolites, at diagnosis and prior to treatment, would improve prediction of survival. We evaluated brain proton MRSI exams in 76 children (median age at diagnosis: 74 months) with brain tumors. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-Oncology
سال: 2018
ISSN: 1522-8517,1523-5866
DOI: 10.1093/neuonc/noy139.369